PepGen (PEPG) Cash from Investing Activities (2021 - 2026)

PepGen (PEPG) reported Cash from Investing Activities of -$1.5 million for Q1 2026, down 108.51% on a YoY basis from $17.1 million in Q1 2025, and up 97.8% sequentially from -$66.2 million in Q4 2025.

PepGen (PEPG) Cash from Investing Activities (2021 - 2026) Analysis & Trends

PepGen (PEPG) has 6 years of Cash from Investing Activities data on file, last reported at -$1.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 108.51% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2026 stood at -$33.8 million (down 266.78% YoY), and the FY2025 full-year result was -$15.2 million, up 59.55% from the prior year.
  • Cash from Investing Activities grew to -$1.5 million in Q1 2026, from -$66.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $26.5 million in Q4 2024 to a low of -$66.2 million in Q4 2025.
  • A 5-year average of -$5.3 million and a median of -$1.0 million in 2023 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities tumbled 5127.35% in 2024 and soared 14312.78% in 2025, its largest moves.
  • Tracing PEPG's Cash from Investing Activities over 5 years: stood at -$1.1 million in 2022, then tumbled by 2584.94% to -$29.6 million in 2023, then surged by 189.57% to $26.5 million in 2024, then tumbled by 349.97% to -$66.2 million in 2025, then surged by 97.8% to -$1.5 million in 2026.
  • Business Quant data shows PEPG's Cash from Investing Activities at -$1.5 million in Q1 2026, -$66.2 million in Q4 2025, and $18.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -45.51 Mn
4 NuCana 279.75 Bn 279.75 Bn - 178,242.27
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 172.62 Mn
10 PepGen 145.09 Mn 145.09 Mn - -1.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.46 Mn
Mar 31, 2026 -1.46 Mn
Dec 31, 2025 -66.24 Mn
Dec 31, 2025 -66.24 Mn
Sep 30, 2025 18.90 Mn
Sep 30, 2025 18.90 Mn
Jun 30, 2025 14.96 Mn
Jun 30, 2025 14.96 Mn
Mar 31, 2025 17.15 Mn
Mar 31, 2025 17.15 Mn
Dec 31, 2024 26.50 Mn
Dec 31, 2024 26.50 Mn
Sep 30, 2024 -133,000.00
Sep 30, 2024 -133,000.00
Jun 30, 2024 -52.74 Mn
Jun 30, 2024 -52.74 Mn
Mar 31, 2024 -11.29 Mn
Mar 31, 2024 -11.29 Mn
Dec 31, 2023 -29.59 Mn
Dec 31, 2023 -29.59 Mn